XML 79 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities:    
Net income (loss) $ 87,551 $ (39,960)
Adjustments to reconcile net income (loss) to net cash provided from operating activities:    
(Gain) loss from equity method investments, net of distributions (1,174) 2,252
Deferred income tax expense (benefit) 62,180 (17,910)
Depletion, depreciation and amortization and impairment 373,192 333,293
Exploration dry hole costs 3,904 832
Mark-to-market on natural gas, NGLs and oil derivatives not designated as hedges (28,350) (30,076)
Abandonment and impairment of unproved properties 46,066 104,048
Unrealized derivative loss 2,485 5,061
Allowance for bad debt 250  
Amortization of deferred financing costs, loss on extinguishment of debt and other 19,735 5,970
Deferred and stock-based compensation 74,187 58,573
(Gain) loss on the sale of assets (89,129) 12,704
Changes in working capital:    
Accounts receivable (6,506) (9,479)
Inventory and other 3,259 (5,394)
Accounts payable (29,234) 11,074
Accrued liabilities and other (15,550) 30,135
Net cash provided from operating activities 502,866 461,123
Investing activities:    
Additions to natural gas and oil properties (907,813) (1,151,167)
Additions to field service assets (4,326) (3,056)
Acreage purchases (70,187) (175,041)
Equity method investments 3,799  
Proceeds from disposal of assets 311,748 32,082
Purchases of marketable securities held by the deferred compensation plan (23,729) (33,997)
Proceeds from the sales of marketable securities held by the deferred compensation plan 19,375 21,485
Net cash used in investing activities (671,133) (1,309,694)
Financing activities:    
Borrowing on credit facilities 1,310,000 1,139,000
Repayment on credit facilities (1,622,000) (865,000)
Issuance of subordinated notes 750,000 600,000
Repayment of subordinated notes (259,063)  
Dividends paid (19,593) (19,475)
Debt issuance costs (12,448) (12,606)
Issuance of common stock 343 2,073
Change in cash overdrafts 4,704 (15,750)
Proceeds from the sales of common stock held by the deferred compensation plan 16,327 20,388
Net cash provided from financing activities 168,270 848,630
Increase in cash and cash equivalents 3 59
Cash and cash equivalents at beginning of period 252 92
Cash and cash equivalents at end of period $ 255 $ 151